Global Pneumococcal Vaccines Disease Analysis Report 202: Overall Likelihood of Approval of a Phase I Pneumococcal Vaccine is 16.7%

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy